国际生物医学工程杂志
國際生物醫學工程雜誌
국제생물의학공정잡지
INTERNATIONAL JOURNAL OF BIOMEDICAL ENGINEERING
2015年
3期
172-175,182
,共5页
D-半乳糖%多聚赖氨酸%还原胺化反应
D-半乳糖%多聚賴氨痠%還原胺化反應
D-반유당%다취뢰안산%환원알화반응
D-galactose%Poly-L-lysine%Reaction of reductive amination
目的:优化制备出具有高效性的肝脏去唾液酸糖蛋白受体(ASGPR)的配体半乳糖化多聚赖氨酸(Gal-PLL),为后期肝靶向性纳米液态氟碳微球超声造影剂的制备以及肝脏靶向分子成像提供依据。方法采用还原胺化法,根据各反应组分的比例不同总体分为实验组(A、B组)和对照组(C组),A、B组又分别细分成3组。 A组将3种不同摩尔比的D-半乳糖和多聚赖氨酸分别与等量的足量还原剂硼氢化钠(NaBH4)进行反应,B组将相同摩尔比的D-半乳糖和多聚赖氨酸分别与3种不同量的还原剂进行反应。各组产物均经葡聚糖凝胶柱分离纯化,得到不同化合物分子质量的达峰曲线并进行分析。结果当还原剂等量时,适量减少D-半乳糖的量,分离纯化的化合物分子质量的达峰曲线提前;当D-半乳糖与多聚赖氨酸摩尔比相等时,适当减少还原剂的量,分离纯化的化合物分子质量的达峰曲线亦出现提前;当D-半乳糖与还原剂的摩尔比为1∶1时,反应合成的半乳糖化多聚赖氨酸化合物与游离组分的曲线分离最为明显,且化合物的量达到最大值。结论当还原剂等量时,适量减少D-半乳糖可增强D-半乳糖与多聚赖氨酸的偶联效果;而当D-半乳糖与多聚赖氨酸摩尔比相等时,适量减少还原剂,D-半乳糖与多聚赖氨酸的偶联效果更佳;当D-半乳糖与还原剂的摩尔比为1∶1时,D-半乳糖与多聚赖氨酸的偶联效果最好。D-半乳糖与多聚赖氨酸的偶联效果不仅与2者的配比相关,也与D-半乳糖与还原剂的配比相关。
目的:優化製備齣具有高效性的肝髒去唾液痠糖蛋白受體(ASGPR)的配體半乳糖化多聚賴氨痠(Gal-PLL),為後期肝靶嚮性納米液態氟碳微毬超聲造影劑的製備以及肝髒靶嚮分子成像提供依據。方法採用還原胺化法,根據各反應組分的比例不同總體分為實驗組(A、B組)和對照組(C組),A、B組又分彆細分成3組。 A組將3種不同摩爾比的D-半乳糖和多聚賴氨痠分彆與等量的足量還原劑硼氫化鈉(NaBH4)進行反應,B組將相同摩爾比的D-半乳糖和多聚賴氨痠分彆與3種不同量的還原劑進行反應。各組產物均經葡聚糖凝膠柱分離純化,得到不同化閤物分子質量的達峰麯線併進行分析。結果噹還原劑等量時,適量減少D-半乳糖的量,分離純化的化閤物分子質量的達峰麯線提前;噹D-半乳糖與多聚賴氨痠摩爾比相等時,適噹減少還原劑的量,分離純化的化閤物分子質量的達峰麯線亦齣現提前;噹D-半乳糖與還原劑的摩爾比為1∶1時,反應閤成的半乳糖化多聚賴氨痠化閤物與遊離組分的麯線分離最為明顯,且化閤物的量達到最大值。結論噹還原劑等量時,適量減少D-半乳糖可增彊D-半乳糖與多聚賴氨痠的偶聯效果;而噹D-半乳糖與多聚賴氨痠摩爾比相等時,適量減少還原劑,D-半乳糖與多聚賴氨痠的偶聯效果更佳;噹D-半乳糖與還原劑的摩爾比為1∶1時,D-半乳糖與多聚賴氨痠的偶聯效果最好。D-半乳糖與多聚賴氨痠的偶聯效果不僅與2者的配比相關,也與D-半乳糖與還原劑的配比相關。
목적:우화제비출구유고효성적간장거타액산당단백수체(ASGPR)적배체반유당화다취뢰안산(Gal-PLL),위후기간파향성납미액태불탄미구초성조영제적제비이급간장파향분자성상제공의거。방법채용환원알화법,근거각반응조분적비례불동총체분위실험조(A、B조)화대조조(C조),A、B조우분별세분성3조。 A조장3충불동마이비적D-반유당화다취뢰안산분별여등량적족량환원제붕경화납(NaBH4)진행반응,B조장상동마이비적D-반유당화다취뢰안산분별여3충불동량적환원제진행반응。각조산물균경포취당응효주분리순화,득도불동화합물분자질량적체봉곡선병진행분석。결과당환원제등량시,괄량감소D-반유당적량,분리순화적화합물분자질량적체봉곡선제전;당D-반유당여다취뢰안산마이비상등시,괄당감소환원제적량,분리순화적화합물분자질량적체봉곡선역출현제전;당D-반유당여환원제적마이비위1∶1시,반응합성적반유당화다취뢰안산화합물여유리조분적곡선분리최위명현,차화합물적량체도최대치。결론당환원제등량시,괄량감소D-반유당가증강D-반유당여다취뢰안산적우련효과;이당D-반유당여다취뢰안산마이비상등시,괄량감소환원제,D-반유당여다취뢰안산적우련효과경가;당D-반유당여환원제적마이비위1∶1시,D-반유당여다취뢰안산적우련효과최호。D-반유당여다취뢰안산적우련효과불부여2자적배비상관,야여D-반유당여환원제적배비상관。
Objective To optimize the preparation of high-efficiency galactocylated poly-L-lysine (Gal-PLL) ligand of the asialoglycoprotein receptor in liver, providing premise and foundation for upper preparation of ultrasound contrast agent of liver targeted nanoscale perfluorocarbon microballoon and the liver targeted molecular imaging. Methods Chemical reactions of reductive amination were carried out on group A and group B according to different proportions of reaction component. Each group was subdivided into three subgroups. In group A, three different molar ratios of D-galactose and poly-L-lysine (PLL) were compounded respectively with equivalent and sufficient reductant borohydride. In group B, identical molar ratios of D-galactose and PLL were compounded respectively with three unequal reductants borohydride. Products of each group were separated and purified by sephadex column to acquire different molecular weight distributions and the results were analyzed. Results In the condition of identical reductant, the peak curve of compound's molecular weight appeared earlier when D-galactose decreased properly. In the condition of identical molar ratio of D-galactose and PLL,the peak curve of compound's molecular weight appeared also earlier when reductant decreased properly. When the molar ratio of D-galactose and reductant was 1∶1, the peak curve of compound Gal-PLL and free components was more obvious, and the quantity of compound Gal-PLL increased to maximum. Conclusions In the condition of identical reductant, coupling effect of D-galactose and PLL increased when D-galactose decreased properly. In the condition of identical molar ratio of D-galactose and PLL, coupling effect was better when reductant decreased properly. When the molar ratio of D-galactose and reductant was 1∶1, coupling effect of them was the best. The coupling of D-galactose and PLL was related to not only the proportion of D-galactose and PLL, but also the proportion of D-galactose and reductant.